What is known about the use of Fabhalta (iptacopan) during pregnancy?

Fabhalta (iptacopan) has no or limited pregnancy data in humans; animal studies showed no reproductive harm at 2–8 times maximum recommended human-dose exposure, and use during pregnancy or when planning pregnancy may only be considered if necessary following careful assessment of risks and benefits.